tiprankstipranks
Advertisement
Advertisement
BriaCell Therapeutics Completes Equity Offering to Fund Operations
PremiumCompany AnnouncementsBriaCell Therapeutics Completes Equity Offering to Fund Operations
2M ago
BriaCell receives recommendation for DSMB for Phase 3 Bria-ABC study
Premium
The Fly
BriaCell receives recommendation for DSMB for Phase 3 Bria-ABC study
2M ago
BriaCell announces data from Bria-IMT at ASCO 2026
Premium
The Fly
BriaCell announces data from Bria-IMT at ASCO 2026
2M ago
BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR
PremiumThe FlyBriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR
3M ago
BriaCell Therapeutics Reports Rising Losses and Funding Pressure
Premium
Company Announcements
BriaCell Therapeutics Reports Rising Losses and Funding Pressure
4M ago
BriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACR
Premium
Company Announcements
BriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACR
4M ago
BriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal
PremiumCompany AnnouncementsBriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal
5M ago
BriaPro to purchase BriaCell’s license to develop, commercialize sCD80
Premium
The Fly
BriaPro to purchase BriaCell’s license to develop, commercialize sCD80
5M ago
BriaCell Wins Fifth Straight Safety Nod for Fast-Track Phase 3 Breast Cancer Trial
Premium
Company Announcements
BriaCell Wins Fifth Straight Safety Nod for Fast-Track Phase 3 Breast Cancer Trial
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100